PBH EBITDA | PRESTIGE CONSUMER HEALTHCARE INC.

PRESTIGE CONSUMER HEALTHCARE INC. (PBH) EBITDA

2026-06-30: Basis Reported; EBITDA $61.27M; Operating income (m); Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA $83.84M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $90.08M*; Operating income $82.49M; Depreciation and amortization $7.59M*.
2025-09-30: Basis Reported; EBITDA $87.33M*; Operating income $79.67M; Depreciation and amortization $7.66M*.

Complete source-backed ebitda history.

Available history: 2010-03-31 to 2026-06-30
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$61.27M	(m)	(m)	(m)	23.06%	$3.70M	$70.79M	(m)	(m)	(m)	$9.36M
2026-03-31	Reported	$83.84M	(m)	(m)	(m)	29.77%	(m)	(m)	(m)	(m)	(m)	(m)
2025-12-31	Reported	$90.08M*	$82.49M	$7.59M*	$283.44M	31.78%*	$3.03M*	$78.29M*	(m)	(m)	(m)	$15.12M
2025-09-30	Reported	$87.33M*	$79.67M	$7.66M*	$274.11M	31.86%*	$2.10M*	$57.49M*	(m)	(m)	(m)	$26.92M
2025-06-30	Reported	$79.42M	(m)	(m)	(m)	31.83%	$838.00K	$79.01M	(m)	(m)	(m)	$14.31M
2025-03-31	Reported	$95.68M	(m)	(m)	(m)	32.27%	(m)	(m)	(m)	(m)	(m)	(m)
2024-12-31	Reported	$98.83M*	$91.96M	$6.87M*	$290.32M	34.04%*	$1.57M*	$65.09M*	(m)	(m)	(m)	$19.12M
2024-09-30	Reported	$92.27M*	$84.34M	$7.93M*	$283.79M	32.51%*	$2.03M*	$69.80M*	(m)	(m)	(m)	$17.29M
2024-06-30	Reported	$80.17M	(m)	(m)	(m)	30.01%	$1.15M	$54.78M	(m)	(m)	(m)	$9.35M
2024-03-31	Reported	$90M	(m)	(m)	(m)	32.49%	(m)	(m)	(m)	(m)	(m)	(m)
2023-12-31	Reported	$94.48M*	$86.83M	$7.65M*	$282.74M	33.42%*	$2.00M*	$71.47M*	(m)	(m)	(m)	$16.53M
2023-09-30	Reported	$95.89M*	$88.25M	$7.64M*	$286.32M	33.49%*	$2.93M*	$62.46M*	(m)	(m)	(m)	$16.86M
2023-06-30	Reported	$92.74M	(m)	(m)	(m)	33.20%	$1.48M	$48.09M	(m)	(m)	(m)	$15.44M
2023-03-31	Reported	-$273.13M	(m)	(m)	(m)	-95.55%	(m)	(m)	(m)	(m)	(m)	(m)
2022-12-31	Reported	$95.31M*	$87.18M	$8.13M*	$275.52M	34.59%*	$1.80M*	$54.94M*	(m)	(m)	(m)	$16.17M
2022-09-30	Reported	$92.63M*	$84.38M	$8.25M*	$289.27M	32.02%*	$2.38M*	$57.54M*	(m)	(m)	(m)	$15.57M
2022-06-30	Reported	$95.4M	(m)	(m)	(m)	34.43%	$1.05M	$58.25M	(m)	(m)	(m)	$15.63M
2022-03-31	Reported	$85.91M	(m)	(m)	(m)	32.18%	(m)	(m)	(m)	(m)	(m)	(m)
2021-12-31	Reported	$90.64M*	$82.59M	$8.05M*	$274.47M	33.03%*	$2.23M*	$66.30M*	(m)	(m)	(m)	$15.28M
2021-09-30	Reported	$86.52M*	$78.56M	$7.96M*	$276.23M	31.32%*	$2.75M*	$61.19M*	(m)	(m)	(m)	$14.30M
2021-06-30	Reported	$98.94M	(m)	(m)	(m)	36.75%	$1.50M	$69.31M	(m)	(m)	(m)	$18.61M
2021-03-31	Reported	$78.47M	(m)	(m)	(m)	33.01%	(m)	(m)	(m)	(m)	(m)	(m)
2020-12-31	Reported	$81.05M*	$73.44M	$7.61M*	$238.79M	33.94%*	$5.73M*	$49.23M*	(m)	(m)	(m)	$12.80M
2020-09-30	Reported	$80.45M*	$72.90M	$7.55M*	$237.42M	33.89%*	$9.07M*	$52.14M*	(m)	(m)	(m)	$7.31M
2020-06-30	Reported	$87.59M	(m)	(m)	(m)	38.18%	$2.55M	$75.15M	(m)	(m)	(m)	$14.46M
2020-03-31	Reported	$81.25M	(m)	(m)	(m)	32.34%	(m)	(m)	(m)	(m)	(m)	$13.49M
2019-12-31	Reported	$83.78M*	$76.40M	$7.38M*	$241.55M	34.69%*	$3.23M*	$58.00M*	(m)	(m)	(m)	$12.50M
2019-09-30	Reported	$76.57M*	$69.35M	$7.22M*	$238.07M	32.16%*	$3.87M*	$50.22M*	(m)	(m)	(m)	$10.76M
2019-06-30	Reported	$78.55M	(m)	(m)	(m)	33.83%	$1.96M	$52.78M	(m)	(m)	(m)	$12.13M
2019-03-31	Reported	-$145.92M	(m)	(m)	(m)	-60.54%	(m)	(m)	(m)	(m)	(m)	-$39.76M
2018-12-31	Reported	$85.43M*	$77.54M	$7.89M*	$241.41M	35.39%*	$2.06M*	$43.33M*	(m)	(m)	(m)	$12.83M
2018-09-30	Reported	$78.92M*	$70.92M	$7.99M*	$239.36M	32.97%*	$2.60M*	$39.26M*	(m)	(m)	(m)	$12.68M
2018-06-30	Reported	$80.86M	(m)	(m)	(m)	31.84%	$2.47M	$55.85M	(m)	(m)	(m)	$11.99M
2018-03-31	Reported	-$15.05M	(m)	(m)	(m)	-5.88%	(m)	(m)	(m)	(m)	(m)	-$12.88M
2017-12-31	Reported	$92.23M*	$83.89M	$8.34M*	$270.62M	34.08%*	$4.87M*	$47.13M*	(m)	(m)	(m)	-$257.15M
2017-09-30	Reported	$84.26M*	$75.72M	$8.53M*	$258.03M	32.66%*	$2.23M*	$54.42M*	(m)	(m)	(m)	$18.62M
2017-06-30	Reported	$87.46M	(m)	(m)	(m)	34.09%	$2.55M	$54.12M	(m)	(m)	(m)	$18.93M
2017-03-31	Reported	$60.18M	(m)	(m)	(m)	25.00%	(m)	(m)	(m)	(m)	(m)	$7.71M
2016-12-31	Reported	$75.14M*	$69.29M	$5.85M*	(m)	(m)	$531.00K*	$40.07M*	(m)	(m)	(m)	$19.09M
2016-09-30	Reported	$77.07M*	$71.06M	$6.02M*	(m)	(m)	$509.00K*	$49.78M*	(m)	(m)	(m)	$18.03M
2016-06-30	Reported	$19.05M	(m)	(m)	(m)	9.09%	$895.00K	$51.30M	(m)	(m)	(m)	-$3.38M
2016-03-31	Reported	$71.47M	(m)	(m)	(m)	34.38%	(m)	(m)	(m)	(m)	(m)	$10.67M
2015-12-31	Reported	$68.71M*	$62.64M	$6.07M*	(m)	(m)	$857.00K*	$45.86M*	(m)	(m)	(m)	$15.19M
2015-09-30	Reported	$75.58M*	$69.90M	$5.69M*	(m)	(m)	$903.00K*	$47.07M*	(m)	(m)	(m)	$17.43M
2015-06-30	Reported	$68.23M	(m)	(m)	(m)	35.51%	$780.00K	$43.52M	(m)	(m)	(m)	$14.00M
2015-03-31	Reported	$67.02M	(m)	(m)	(m)	35.26%	(m)	(m)	(m)	(m)	(m)	$13.68M
2014-12-31	Reported	$62.15M*	$56.99M	$5.15M*	(m)	(m)	$2.32M*	$47.08M*	(m)	(m)	(m)	$12.24M
2014-09-30	Reported	$50.37M*	$46.52M	$3.85M*	(m)	(m)	$884.00K*	$27.39M*	(m)	(m)	(m)	$11.86M
2014-06-30	Reported	$45.76M	(m)	(m)	(m)	31.41%	$496.00K	$29.67M	(m)	(m)	(m)	$11.42M
2014-03-31	Reported	$48.23M	(m)	(m)	(m)	33.72%	(m)	(m)	(m)	(m)	(m)	$10.70M
2013-12-31	Reported	$44.10M*	$40.46M	$3.65M*	(m)	(m)	$339.00K*	$25.26M*	(m)	(m)	(m)	$1.06M
2013-09-30	Reported	$57.06M*	$53.76M	$3.29M*	(m)	(m)	$955.00K*	$32.80M*	(m)	(m)	(m)	$4.53M
2013-06-30	Reported	$52.71M	(m)	(m)	(m)	36.99%	$1.36M	$22.80M	(m)	(m)	(m)	$12.84M
2013-03-31	Reported	$53.46M	(m)	(m)	(m)	35.39%	(m)	(m)	(m)	(m)	(m)	$11.14M
2012-12-31	Reported	$50.08M*	$46.72M	$3.36M*	(m)	(m)	$3.66M*	$40.50M*	(m)	(m)	(m)	$7.80M
2012-09-30	Reported	$54.45M*	$51.16M	$3.30M*	(m)	(m)	$4.07M*	$45.63M*	(m)	(m)	(m)	$12.25M
2012-06-30	Reported	$47.13M	(m)	(m)	(m)	32.06%	$1.20M	$14.74M	(m)	(m)	(m)	$9.33M
2012-03-31	Reported	$25.61M	(m)	(m)	(m)	19.11%	(m)	(m)	(m)	(m)	(m)	$815.00K
2011-12-31	Reported	$26.19M*	$23.63M	$2.56M*	(m)	(m)	$51.00K*	$14.53M*	(m)	(m)	(m)	$6.00M
2011-09-30	Reported	$31.97M*	$29.40M	$2.57M*	(m)	(m)	$231.00K*	$18.02M*	(m)	(m)	(m)	$8.17M
2011-06-30	Reported	$29.79M	(m)	(m)	(m)	31.26%	$76.00K	$15.44M	(m)	(m)	(m)	$8.95M
2011-03-31	Reported	$21.17M	(m)	(m)	(m)	21.97%	(m)	(m)	(m)	(m)	(m)	(m)
2010-12-31	Reported	$15.54M*	$13.02M	$2.51M*	(m)	(m)	$151.00K*	$18.84M*	(m)	(m)	(m)	$3.20M
2010-09-30	Reported	$26.34M*	$23.84M	$2.50M*	(m)	(m)	$124.00K*	$22.10M*	(m)	(m)	(m)	$7.05M
2010-06-30	Reported	$23.21M	(m)	(m)	(m)	32.58%	$130.00K	$20.71M	(m)	(m)	(m)	$5.69M

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-03-31	Reported	$340.68M	(m)	(m)	(m)	31.29%	$11.18M	$257.63M	(m)	(m)	(m)	$67.19M
2025-03-31	Reported	$366.95M	(m)	(m)	(m)	32.25%	$8.22M	$251.51M	(m)	(m)	(m)	$69.58M
2024-03-31	Reported	$373.1M	(m)	(m)	(m)	33.15%	$9.55M	$248.93M	(m)	(m)	(m)	$66.69M
2023-03-31	Reported	$10.21M	(m)	(m)	(m)	0.91%	$7.78M	$229.72M	(m)	(m)	(m)	-$11.61M
2022-03-31	Reported	$362.01M	(m)	(m)	(m)	33.31%	$9.64M	$259.92M	(m)	(m)	(m)	$57.08M
2021-03-31	Reported	$327.57M	(m)	(m)	(m)	34.72%	$22.24M	$235.61M	(m)	(m)	(m)	$39.43M
2020-12-31	Rolling	(m)	$300.38M*	(m)	$956.84M*	(m)	(m)	(m)	(m)	(m)	(m)	$48.06M*
2020-09-30	Rolling	(m)	$303.34M*	(m)	$959.60M*	(m)	(m)	(m)	(m)	(m)	(m)	$47.75M*
2020-06-30	Rolling	(m)	$299.79M*	(m)	$960.25M*	(m)	(m)	(m)	(m)	(m)	(m)	$51.21M*
2020-03-31	Reported	$320.15M	(m)	(m)	(m)	33.24%	$14.56M	$217.12M	(m)	(m)	(m)	$48.87M
2020-03-31	Rolling	(m)	$291.15M*	(m)	$963.01M*	(m)	(m)	(m)	(m)	(m)	(m)	$48.87M*
2019-12-31	Rolling	(m)	$63.79M*	(m)	$952.80M*	(m)	(m)	(m)	(m)	(m)	(m)	-$4.38M*
2019-09-30	Rolling	(m)	$64.93M*	(m)	$952.66M*	(m)	(m)	(m)	(m)	(m)	(m)	-$4.04M*
2019-06-30	Rolling	(m)	$66.50M*	(m)	$953.95M*	(m)	(m)	(m)	(m)	(m)	(m)	-$2.12M*
2019-03-31	Reported	$99.28M	(m)	(m)	(m)	10.17%	$10.48M	$189.28M	(m)	(m)	(m)	-$2.25M
2019-03-31	Rolling	(m)	$67.50M*	(m)	$975.78M*	(m)	(m)	(m)	(m)	(m)	(m)	-$2.25M*
2018-12-31	Rolling	(m)	$197.86M*	(m)	$990.72M*	(m)	(m)	(m)	(m)	(m)	(m)	$24.63M*
2018-09-30	Rolling	(m)	$204.21M*	(m)	$1.02B*	(m)	(m)	(m)	(m)	(m)	(m)	-$245.36M*
2018-06-30	Rolling	(m)	$209.01M*	(m)	$1.04B*	(m)	(m)	(m)	(m)	(m)	(m)	-$239.42M*
2018-03-31	Reported	$248.9M	(m)	(m)	(m)	23.91%	$12.53M	$210.11M	(m)	(m)	(m)	-$232.48M
2018-03-31	Rolling	(m)	$215.47M*	(m)	$1.04B*	(m)	(m)	(m)	(m)	(m)	(m)	-$232.48M*
2017-12-31	Rolling	(m)	$291.62M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	-$211.90M*
2017-09-30	Rolling	(m)	$277.02M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$64.35M*
2017-06-30	Rolling	(m)	$272.35M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$63.77M*
2017-03-31	Reported	$231.44M	(m)	(m)	(m)	26.24%	$2.98M	$148.67M	(m)	(m)	(m)	$41.45M
2017-03-31	Rolling	(m)	$205.61M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$41.45M*
2016-12-31	Rolling	(m)	$217.83M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$44.41M*
2016-09-30	Rolling	(m)	$211.18M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$40.50M*
2016-06-30	Rolling	(m)	$210.02M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$39.90M*
2016-03-31	Reported	$283.99M	(m)	(m)	(m)	35.22%	$3.57M	$176.31M	(m)	(m)	(m)	$57.28M
2016-03-31	Rolling	(m)	$260.31M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$57.28M*
2015-12-31	Rolling	(m)	$256.29M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$60.29M*
2015-09-30	Rolling	(m)	$250.64M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$57.34M*
2015-06-30	Rolling	(m)	$227.26M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$51.78M*
2015-03-31	Reported	$225.3M	(m)	(m)	(m)	31.53%	$6.10M	$156.25M	(m)	(m)	(m)	$49.20M
2015-03-31	Rolling	(m)	$207.56M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$49.20M*
2014-12-31	Rolling	(m)	$191.27M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$46.22M*
2014-09-30	Rolling	(m)	$174.73M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$35.04M*
2014-06-30	Rolling	(m)	$181.98M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$27.71M*
2014-03-31	Reported	$202.1M	(m)	(m)	(m)	33.83%	$2.76M	$111.58M	(m)	(m)	(m)	$29.13M
2014-03-31	Rolling	(m)	$188.62M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$29.13M*
2013-12-31	Rolling	(m)	$193.83M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$29.57M*
2013-09-30	Rolling	(m)	$200.10M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$36.32M*
2013-06-30	Rolling	(m)	$197.49M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$44.04M*
2013-03-31	Reported	$205.12M	(m)	(m)	(m)	33.08%	$10.27M	$137.60M	(m)	(m)	(m)	$40.53M
2013-03-31	Rolling	(m)	$191.88M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$40.53M*
2012-12-31	Rolling	(m)	$164.27M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$30.20M*
2012-09-30	Rolling	(m)	$141.18M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$28.40M*
2012-06-30	Rolling	(m)	$119.42M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$24.32M*
2012-03-31	Reported	$113.56M	(m)	(m)	(m)	25.74%	$606.00K	$67.45M	(m)	(m)	(m)	$23.95M
2012-03-31	Rolling	(m)	$102.82M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$23.95M*
2011-03-31	Reported	$86.25M	(m)	(m)	(m)	25.63%	$655.00K	$86.67M	(m)	(m)	(m)	$19.35M
2010-03-31	Reported	$89.78M	(m)	(m)	(m)	30.68%	$673.00K	$59.43M	(m)	(m)	(m)	$20.66M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
OCULAR THERAPEUTIX, INC (OCUL)	United States	$2.159B	-7.15
Aurinia Pharmaceuticals Inc. (AUPH)		$2.207B	7.18
Bausch Health Companies Inc. (BHC)		$2.113B	-1.68
Braveheart Bio, Inc. (BRVE)	United States	$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)	United States	$2.105B	-35.55
Trevi Therapeutics, Inc. (TRVI)	United States	$2.091B	-51.93
Zai Lab Ltd (ZLAB)		$2.241B	-113.34
Generate Biomedicines, Inc. (GENB)	United States	$2.052B
PERRIGO Co plc (PRGO)	Ireland	$2.038B	-0.79
NEKTAR THERAPEUTICS (NKTR)	United States	$2.026B	-9.05